Rituxan 500 MG/50 ML vial 50ML
Ended Awarded
- Contract number
- SPE2DB25FWUWJ
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $29,829
Award facts
- Contract value 100% obligated
- $29,829.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, a firm fixed-price delivery order valued at $29,829.40 for Rituxan 500 mg/50 ml vials. The delivery order was issued on September 10, 2025, with an ultimate completion date of October 1, 2025, and carries no set-aside designation. This award represents a single delivery order under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA's SPE2DB program, a $500 million vehicle valid through November 2026 that enables the agency to procure a comprehensive range of pharmaceutical products for military health facilities.
Rituxan is a monoclonal antibody therapy used primarily in the treatment of certain cancers and autoimmune disorders, reflecting DLA's broad pharmaceutical supply mission supporting Department of Defense healthcare operations. DMS Pharmaceutical Group has established itself as a key supplier within the federal pharmaceutical supply chain, leveraging its woman-owned small business status to compete effectively in federal procurement while maintaining a robust portfolio of pharmaceutical product deliveries across multiple therapeutic categories including oncology treatments, biologics, and specialty medications to military healthcare facilities nationwide.
Quick answers
Who was awarded contract SPE2DB25FWUWJ?
SPE2DB25FWUWJ was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 10, 2025.
How much is contract SPE2DB25FWUWJ worth?
The government has obligated $29,829 on SPE2DB25FWUWJ.
Is contract SPE2DB25FWUWJ an order under another contract?
Yes. SPE2DB25FWUWJ is a delivery order under SPE2DB25D9312, an indefinite delivery contract.
Was contract SPE2DB25FWUWJ competed?
The extent of competition for SPE2DB25FWUWJ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award